Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.BO)
INR 688.55
(0.19%)
INR 688.55
(0.19%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 2.08 Billion | 2.36 Billion | 2.17 Billion | 1.87 Billion | 1.58 Billion | 1.66 Billion |
| Cost of Revenue | 1.43 Billion | 932.72 Million | 892.82 Million | 809.34 Million | 562.51 Million | 729.32 Million |
| Gross Profit | 652.59 Million | 1.43 Billion | 1.28 Billion | 1.07 Billion | 1.02 Billion | 938.93 Million |
| Operating Expenses | 773.41 Million | 1.09 Billion | 1.03 Billion | 882.25 Million | 949.13 Million | 854.42 Million |
| Selling, General and Administrative Expenses | 773.41 Million | 243.72 Million | 240.52 Million | 172.62 Million | 201.54 Million | 146.94 Million |
| Research and Development Expenses | - | - | - | 3.45 Million | 1.54 Million | 1.2 Million |
| Other Expenses | - | 11.13 Million | 1.74 Million | 3.56 Million | 3.74 Million | 1.32 Million |
| Cost and Expenses | 1.57 Billion | 2.02 Billion | 1.93 Billion | 1.69 Billion | 1.51 Billion | 1.58 Billion |
| Operating Income | 508.13 Million | 342.07 Million | 246.17 Million | 180.16 Million | 74.83 Million | 83.25 Million |
| Interest Expense | 8.14 Million | 2.78 Million | 2.61 Million | 4.27 Million | 3.83 Million | 4.44 Million |
| Income Tax Expense | 74.06 Million | 80.87 Million | 77.87 Million | 48.14 Million | 15.44 Million | 17.86 Million |
| Earnings before Tax | 298.69 Million | 348.08 Million | 266.42 Million | 218.72 Million | 94.14 Million | 90.02 Million |
| Net Income | 224.63 Million | 267.21 Million | 188.55 Million | 170.58 Million | 78.7 Million | 72.16 Million |
| Earnings Per Share Basic | 8.49 | 10.20 | 7.20 | 6.51 | 3.00 | 2.75 |
| Earnings Per Share Diluted | 8.46 | 10.20 | 7.20 | 6.51 | 3.00 | 2.75 |
| Weighted Average Shares Outstanding | 26.44 Million | 26.19 Million | 26.19 Million | 26.19 Million | 26.19 Million | 26.19 Million |
| Weighted Average Shares Outstanding (Diluted) | 26.55 Million | 26.19 Million | 26.19 Million | 26.19 Million | 26.19 Million | 26.19 Million |
| Gross Margin | 0.31 | 0.61 | 0.59 | 0.57 | 0.65 | 0.56 |
| EBIT Margin | 0.15 | 0.17 | 0.13 | 0.12 | 0.07 | 0.06 |
| Profit Margin | 0.11 | 0.11 | 0.09 | 0.09 | 0.05 | 0.04 |
| EBITDA | 323.46 Million | 363.96 Million | 255.13 Million | 198.72 Million | 85.32 Million | 93.35 Million |
| Earnings Before Tax Margin | 0.24 | 0.14 | 0.11 | 0.10 | 0.05 | 0.05 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 746.92 Million | 614.39 Million | 2.08 Billion | 434.86 Million | 472.34 Million | 578.29 Million |
| Cost of Revenue | 263.61 Million | 405.4 Million | 1.43 Billion | 317.87 Million | 197.41 Million | 209.09 Million |
| Gross Profit | 483.31 Million | 208.99 Million | 652.59 Million | 116.99 Million | 274.93 Million | 369.2 Million |
| Operating Expenses | 343.87 Million | 117.33 Million | 438.55 Million | 94.33 Million | 245.09 Million | 290.1 Million |
| Selling, General and Administrative Expenses | 132.46 Million | 117.33 Million | - | 94.33 Million | 98.03 Million | 126.7 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 343.87 Million | 14.44 Million | 92.79 Million | 24.87 Million | 25.21 Million | 22.74 Million |
| Cost and Expenses | 607.48 Million | 522.73 Million | 1.87 Billion | 412.2 Million | 442.5 Million | 499.19 Million |
| Operating Income | 139.44 Million | 91.66 Million | 214.04 Million | 22.66 Million | 29.84 Million | 79.1 Million |
| Interest Expense | 2.29 Million | 2.15 Million | 8.14 Million | 2.17 Million | 2.26 Million | 2.21 Million |
| Income Tax Expense | 39.1 Million | 17.81 Million | 74.06 Million | 9.87 Million | 13.16 Million | 24.91 Million |
| Earnings before Tax | 153.69 Million | 71.1 Million | 298.69 Million | 45.36 Million | 52.79 Million | 99.63 Million |
| Net Income | 114.59 Million | 53.29 Million | 224.63 Million | 35.49 Million | 39.63 Million | 74.72 Million |
| Earnings Per Share Basic | 4.29 | 2.01 | - | 1.31 | 1.51 | 2.85 |
| Earnings Per Share Diluted | 4.25 | 1.93 | - | 1.31 | 1.47 | 2.85 |
| Weighted Average Shares Outstanding | 26.71 Million | 26.45 Million | 26.55 Million | 27.09 Million | 26.28 Million | 26.19 Million |
| Weighted Average Shares Outstanding (Diluted) | 26.96 Million | 27.61 Million | 26.55 Million | 27.09 Million | 26.95 Million | 26.19 Million |
| Gross Margin | 0.65 | 0.34 | 0.31 | 0.27 | 0.58 | 0.64 |
| EBIT Margin | 0.24 | 0.17 | - | 0.06 | 0.13 | 0.18 |
| Profit Margin | 0.15 | 0.09 | 0.11 | 0.08 | 0.08 | 0.13 |
| EBITDA | 179.39 Million | 102.38 Million | - | 26.69 Million | 59.17 Million | 106.39 Million |
| Earnings Before Tax Margin | 0.19 | 0.15 | 0.10 | 0.05 | 0.06 | 0.14 |
6262
WEWIN
IG6
INNOCORP
PLLTL
SEMAC